Trials / Completed
CompletedNCT03248375
Impact of Y90 Radiation Segmentectomy on HCC
The Impact of 90Yttrium (Y90) Radiation Segmentectomy on Hepatocellular Carcinoma and Cirrhosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- Icahn School of Medicine at Mount Sinai · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this pilot study is to assess the efficacy of radiation segmentectomy with Theraspheres in patients with unresectable hepatocellular carcinoma that would qualify for thermal ablation as per the BCLC guidelines, but are unable to receive thermal ablation due to unfavorable location of target lesions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Radiation Segmentectomy | The administration of radioactivity in a branch of an artery of the liver |
Timeline
- Start date
- 2016-08-03
- Primary completion
- 2021-03-31
- Completion
- 2021-03-31
- First posted
- 2017-08-14
- Last updated
- 2023-02-13
- Results posted
- 2023-02-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03248375. Inclusion in this directory is not an endorsement.